Abstract
The 2011 figures in the orthopedic biomaterials market show great promise for
future performance of the orthopedic biomaterials market. To date there has
been a multitude of products introduced to the market, with some becoming
spectacular successes. Future growth for this market will be a result of
continued improvements in product technology to meet the needs of patients as
well as changes in healthcare reform and reimbursement. This comprehensive
report covers a number of disciplines, including spinal surgery, sports
medicine, tissue donation, and biotechnology. In each segment of this report,
current market conditions are thoroughly examined and the behavior of each
sub-segment over the forecast period is critically analyzed and cross-verified.
The Orthopedic biomaterials market includes:
- bone graft substitutes,
- growth factors,
- machined allografts,
- hyaluronic acid viscosupplementation,
- resorbable fixation devices,
- tendon grafts,
- cartilage repair,
- platelet and bone marrow concentration,
- orthopedic stem cells and
- emerging technologies
This report provides a comprehensive and detailed analysis of market revenues
by device type, market forecasts through 2018, unit sales, average selling
prices, market drivers and limiters and a detailed competitive analysis,
including manufacturer market shares and product portfolios.
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
- 1.1 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS
- 1.2 ORTHOPEDIC BIOMATERIAL MARKET GROWTH RATES
- 1.3 BONE GRAFT SUBSTITUTE USAGE PER INDICATION
- 1.4 MACHINED BONE ALLOGRAFT MARKET
- 1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- 1.6 RESORBABLE FIXATION DEVICE MARKET
- 1.7 TENDON GRAFT MARKET
- 1.8 CARTILAGE REPAIR MARKET
- 1.9 PLATELET AND BONE MARROW CONCENTRATION MARKET
- 1.10 ORTHOPEDIC STEM CELL MARKET
- 1.11 LEADING COMPETITORS
RESEARCH METHODOLOGY
- 2.1 RESEARCH SCOPE
- 2.2 IDATA'S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
- 3.1 INTRODUCTION
- 3.1.1 Growth Factors
- 3.1.2 Bone Graft Substitutes
- 3.1.3 Machined Bone Allografts
- 3.1.4 Hyaluronic Acid Viscosupplementation
- 3.1.5 Resorbable Fixation Devices
- 3.1.6 Tendon Grafts
- 3.1.7 Cartilage Repair
- 3.1.8 Platelet and Bone Marrow Concentration
- 3.1.9 Orthopedic Stem Cell Therapy
- 3.2 MARKET ANALYSIS AND FORECAST
- 3.2.2 Trend Analysis
- 3.3 MARKET DRIVERS AND LIMITERS
- 3.3.2 Market Limiters
- 3.4 COMPETITIVE ANALYSIS
- 3.4.1 Market Concentration
- 3.5 MERGERS AND ACQUISITIONS
- 3.5.1.1 Osteotech Acquired Distributorship of Harvest Technologies System
- 3.5.1.2 Regeneration Technologies Merged with Tutogen Medical Inc
- 3.5.1.3 NuVasive Acquired Osiris Therapeutics' OsteocelR Product
- 3.5.1.4 NuVasive Acquired Cervitech
- 3.5.1.5 Biomet Acquired Cartilix
- 3.5.1.6 Alphatec Holdings Acquired Scient'x Groupe
- 3.5.1.7 Anika Acquired Fidia Advanced Biopolymers
- 3.5.1.8 Baxter International Acquired ApaTech
- 3.5.1.9 Stryker Acquired Orthovita
- 3.5.1.10 Olympus Biotech Acquired OP-1TM from Stryker
- 3.5.1.11 Histogenics Acquired ProChon Biotech
GROWTH FACTOR MARKET
- 4.1 INTRODUCTION
- 4.1.1 Overview
- 4.1.2 BMP-2 (Medtronic)
- 4.1.3 BMP-7 (Olympus Biomaterials)
- 4.1.4 Potential Complications
- 4.1.5 Reimbursement
- 4.1.6 Future Indications
- 4.2 MARKET ANALYSIS AND FORECAST
- 4.3 MARKET DRIVERS AND LIMITERS
- 4.3.1 Market Drivers
- 4.3.2 Market Limiters
- 4.4 COMPETITIVE ANALYSIS
- 4.4.1 Leading Competitors
- 4.4.2 Potential Competitors
BONE GRAFT SUBSTITUTE MARKET
- 5.1 INTRODUCTION
- 5.2 MARKET SEGMENTATION
- 5.2.1 Indications
- 5.2.1.2 Trauma
- 5.2.1.3 Extremities
- 5.2.2 Materials
- 5.2.2.1 Autografts
- 5.2.2.2 Standard Allografts
- 5.2.2.3 Demineralized Bone Matrix
- 5.2.2.4 Synthetics
- 5.2.2.5 Xenografts
- 5.3 PROCEDURES
- 5.3.1 Total Procedures
- 5.3.2 Spinal Procedures
- 5.4 UNITS PER PROCEDURE
- 5.5 MARKET OVERVIEW
- 5.5.1 Market by Material
- 5.5.2 Market by Indication
- 5.6 MARKET ANALYSIS AND FORECAST
- 5.6.1.1 Spinal Bone Graft Substitute Market
- 5.6.1.2 Cervical Spinal Bone Graft Substitute Market
- 5.6.1.3 Thoracolumbar Spinal Bone Graft Substitute Market
- 5.6.1.4 Trauma Bone Graft Substitute Market
- 5.6.1.5 Large Joint Reconstruction Bone Graft Substitute Market
- 5.6.1.6 Foot Reconstruction Bone Graft Substitute Market
- 5.6.1.7 Craniomaxillofacial Bone Graft Substitute Market
- 5.6.1.8 Oncology Bone Graft Substitute Market
- 5.6.2 Bone Graft Substitute Market by Material
- 5.6.2.1 Allograft
- 5.6.2.1.1 Total Allograft Market
- 5.6.2.1.2 Spinal Allograft
- 5.6.2.1.2.1 Cervical Spinal Allograft
- 5.6.2.1.2.2 Thoracolumbar Spinal Allograft
- 5.6.2.1.3 Trauma Allograft
- 5.6.2.1.3.1 Non-Union Fracture Allograft Market
- 5.6.2.1.3.2 Fresh-Fracture Allograft Market
- 5.6.2.1.4 Joint Reconstruction Allograft
- 5.6.2.1.4.1 Hip Reconstruction Allograft
- 5.6.2.1.4.2 Knee Reconstruction Allograft
- 5.6.2.1.5 Foot Reconstruction Allograft
- 5.6.2.1.6 Craniomaxillofacial Allograft
- 5.6.2.1.7 Oncology Allograft
- 5.6.2.2 Demineralized Bone Matrices
- 5.6.2.2.1 Total DBM Market
- 5.6.2.2.2 Spinal DBM
- 5.6.2.2.2.1 Cervical Spinal DBM
- 5.6.2.2.2.2 Thoracolumbar Spinal DBM
- 5.6.2.2.3 Trauma DBM
- 5.6.2.2.3.1 Non-Union DBM
- 5.6.2.2.3.2 Fresh-Fracture DBM
- 5.6.2.2.4 Joint Reconstruction DBM
- 5.6.2.2.4.1 Hip Reconstruction DBM
- 5.6.2.2.4.2 Knee Reconstruction DBM
- 5.6.2.2.5 Foot Reconstruction DBM
- 5.6.2.2.6 Craniomaxillofacial DBM Market
- 5.6.2.2.7 Oncology DBM
- 5.6.2.3 Synthetic Bone Graft Substitute Market
- 5.6.2.3.1 Total Synthetic Market
- 5.6.2.3.2 Spinal Synthetic
- 5.6.2.3.2.1 Cervical Synthetic
- 5.6.2.3.2.2 Thoracolumbar Synthetic
- 5.6.2.3.3 Trauma Synthetic
- 5.6.2.3.3.1 Non-Union Fracture Synthetic
- 5.6.2.3.3.2 Fresh Fracture Synthetic
- 5.6.2.3.4 Joint Reconstruction Synthetic
- 5.6.2.3.4.1 Hip Reconstruction Synthetic
- 5.6.2.3.4.2 Knee Reconstruction Synthetic
- 5.6.2.3.5 Foot Synthetic
- 5.6.2.3.6 Craniomaxillofacial Synthetic
- 5.6.2.3.7 Oncology Synthetic
- 5.7 MARKET DRIVERS AND LIMITERS
- 5.7.1 Market Drivers
- 5.7.1.1 Standard Allograft Market
- 5.7.1.2 DBM Market
- 5.7.1.3 Synthetic Market
- 5.7.2 Market Limiters
- 5.7.2.1 Standard Allograft Market
- 5.7.2.2 DBM Market
- 5.7.2.3 Synthetic Market
- 5.8 COMPETITIVE ANALYSIS
- 5.8.1 Bone Graft Substitute Market
- 5.8.1.1 Allograft Market
- 5.8.1.2 DBM Market
- 5.8.1.3 Synthetic Bone Graft Substitute Market
ORTHOPEDIC STEM CELL MARKET
- 6.1 INTRODUCTION
- 6.2 MARKET OVERVIEW
- 6.2.1 Lineage
- 6.2.1.1 Human Embryonic Stem Cells (hESC)
- 6.2.1.2 Mesenchymal Stem Cells (MSC)
- 6.2.2 Legislation
- 6.2.3 Other Therapeutic Applications
- 6.3 MARKET ANALYSIS AND FORECAST
- 6.3.1 Total Market
- 6.3.1.1 Lumbar Spine Stem Cell Market
- 6.3.1.2 Cervical Spine Stem Cell Market
- 6.4 MARKET DRIVERS AND LIMITERS
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
- 6.5 COMPETITIVE ANALYSIS
- 6.5.1 Leading Competitors
- 6.5.2 Potential Competitors
MACHINED BONE ALLOGRAFT MARKET
- 7.1 INTRODUCTION
- 7.1.1 Approaches
- 7.1.1.1 Anterior Lumbar Interbody Fusion (ALIF)
- 7.1.1.2 Posterior Lumbar Interbody Fusion (PLIF)
- 7.1.1.3 Transforaminal Lumbar Interbody Fusion (TLIF)
- 7.1.1.4 Extreme Lateral Interbody Fusion (XLIF)
- 7.1.1.5 Cervical
- 7.2 PROCEDURES
- 7.3 MARKET OVERVIEW
- 7.4 MARKET FORECAST AND ANALYSIS
- 7.4.1 ALIF Approach
- 7.4.2 PLIF Approach
- 7.4.3 TLIF Approach
- 7.4.4 Cervical Machined Bone Allografts
- 7.5 MARKET DRIVERS AND LIMITERS
- 7.5.1 Market Drivers
- 7.5.2 Market Limiters
- 7.6 COMPETITIVE ANALYSIS
PLATELET AND BONE MARROW ASPIRATE CONCENTRATION MARKET
- 8.1 INTRODUCTION
- 8.1.1 Platelet Rich Plasma
- 8.1.2 Bone Marrow Aspirate
- 8.2 MARKET OVERVIEW
- 8.3 MARKET ANALYSIS AND FORECAST
- 8.3.1 Total Platelet Concentration Market
- 8.3.1.1 Spinal Platelet Concentration Market
- 8.3.1.2 Extremity and Sports Medicine Platelet Concentration Market
- 8.3.2 Total Bone Marrow Aspirate Concentration Market
- 8.4 MARKET DRIVERS AND LIMITERS
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
- 8.5 COMPETITIVE ANALYSIS
TENDON GRAFT MARKET
- 9.1 INTRODUCTION
- 9.1.1 Repair Methods
- 9.1.1.1 Bone-Patellar Tendon-Bone (BTB) Graft, ACL/PCL Surgery
- 9.1.1.2 Soft Tissue Grafts
- 9.1.1.3 Allograft Tendons
- 9.1.1.4 Ligament and Tendon Synthetic Grafts
- 9.2 PROCEDURES
- 9.3 MARKET FORECAST AND ANALYSIS
- 9.4 MARKET DRIVERS AND LIMITERS
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
- 9.5 COMPETITIVE ANALYSIS
CARTILAGE REPAIR MARKET
- 10.1 INTRODUCTION
- 10.1.1 Methods for Cartilage Repair
- 10.2 PROCEDURES
- 10.3 MARKET ANALYSIS AND FORECAST
- 10.3.1 Cartilage Repair Market
- 10.3.2 Autologous Chondrocyte Implantation Market
- 10.3.3 Osteochondral Allograft Market
- 10.3.4 Meniscal Graft Market
- 10.4 MARKET DRIVERS AND LIMITERS
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
- 10.5 COMPETITIVE ANALYSIS
- 10.5.1 Leading Competitors
- 10.5.2 Emerging Competitors
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
- 11.1 INTRODUCTION
- 11.1.1 Benefits of Viscosupplementation
- 11.1.2 Synovial Fluid
- 11.1.3 Product Types
- 11.1.3.1 Single-Injection Products
- 11.1.3.2 Three-Injection Cycle Products
- 11.1.3.3 Three/Five-Injection Cycle Products
- 11.1.4 Reimbursement
- 11.2 MARKET OVERVIEW
- 11.3 MARKET ANALYSIS AND FORECAST
- 11.3.1 Total Market
- 11.3.1.1 Single-Injection Hyaluronic Acid Viscosupplementation Market
- 11.3.1.2 Three-Injection Cycle Hyaluronic Acid Viscosupplementation
Market
- 11.3.1.3 Five-Injection Cycle Hyaluronic Acid Viscosupplementation
Market
- 11.4 MARKET DRIVERS AND LIMITERS
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
- 11.5 COMPETITIVE ANALYSIS
RESORBABLE FIXATION MARKET
- 12.1 INTRODUCTION
- 12.1.1 Materials
- 12.1.2 Disadvantages Compared to Metal Fixation
- 12.1.3 Indications and Product Descriptions
- 12.1.3.1 Shoulder Fixation
- 12.1.3.2 Knee Reconstruction
- 12.2 MARKET OVERVIEW
- 12.3 MARKET ANALYSIS AND FORECAST
- 12.3.1 Resorbable Fixation Market
- 12.3.2 ACL/PCL Resorbable Fixation Market
- 12.3.2.1 Femoral Fixation
- 12.3.2.2 Tibia Fixation Market
- 12.3.3 Meniscal Resorbable Fixation Market
- 12.3.4 Rotator Cuff Resorbable Fixation Market
- 12.3.5 Labrum Repair Market
- 12.4 MARKET DRIVERS AND LIMITERS
- 12.4.1 Market Drivers
- 12.4.1.1 Shoulder Fixation
- 12.4.1.2 Knee Fixation
- 12.4.2 Market Limiters
- 12.4.2.1 Shoulder Fixation
- 12.4.2.2 Knee Fixation
- 12.5 COMPETITIVE ANALYSIS
- 12.5.1 Leading Competitors
- 12.5.2 Other Notable Competitors
ABBREVIATIONS
